Skip to content
Clinical Trials – home

Tricuspid valve disease Diagnostics

1 / 1 trials open to patients1 country

In short

Tricuspid valve disease affects the valve between the heart's right upper and lower chambers, and diagnosing this condition early can make a significant difference in managing symptoms and preventing complications. Understanding the diagnostic process can help you know when to seek medical attention and what to expect during evaluation.

Key points

  • Tricuspid valve disease often develops silently without symptoms until it becomes severe, making awareness of risk factors and warning signs crucial for early detection.[1]
  • The echocardiogram is the most important diagnostic tool, using safe sound waves to create detailed images showing how your tricuspid valve is functioning.[4]
  • A simple physical exam can sometimes detect tricuspid valve problems through heart murmurs, enlarged neck veins, or swelling, but imaging tests are needed to confirm the diagnosis.[4]
  • Women face more than four times the risk of developing tricuspid regurgitation compared to men, highlighting the importance of gender-specific awareness.[10]
  • People with other heart conditions, atrial fibrillation, or a history of heart surgery should discuss tricuspid valve screening with their doctors even without symptoms.[4]
  • Clinical trials for new treatments require comprehensive diagnostic documentation including detailed echocardiogram measurements and symptom assessments.[11]
  • Regular monitoring through repeat testing is essential even with mild disease, as tricuspid valve problems tend to worsen gradually over time.[2]
  • Early diagnosis and treatment can significantly improve outcomes, with new minimally invasive procedures reducing heart failure hospitalizations by 28% at two years.[20]

Introduction: Who Should Seek Tricuspid Valve Diagnostics

Many people with tricuspid valve disease may not realize they have a problem for quite some time. The condition can develop slowly and remain silent until it becomes more severe. This makes knowing when to seek medical evaluation especially important for protecting your heart health.

You should consider seeking diagnostic evaluation if you experience certain warning signs that suggest your heart may not be working as well as it should. These symptoms include feeling unusually tired or weak even after normal activities, noticing swelling in your legs, ankles, feet, or abdomen, experiencing shortness of breath especially during physical activity, or feeling a pulsing or fluttering sensation in your chest or neck. Some people also report feeling abnormally cold in their skin or having difficulty keeping up with tasks they used to manage easily.

It's also advisable to undergo diagnostic testing if you have other heart conditions, since tricuspid valve disease often occurs alongside problems with other heart valves, particularly the mitral or aortic valves. People with a history of heart failure, high blood pressure in the lungs (called pulmonary hypertension), or irregular heart rhythms like atrial fibrillation are at higher risk and may benefit from regular monitoring even if they don't yet have symptoms.

Additionally, certain medical conditions and past treatments can increase your chances of developing tricuspid valve problems. If you've had rheumatic fever, infections of the heart lining called endocarditis, chest radiation therapy, heart surgery, or if you were born with heart defects, your healthcare provider may recommend diagnostic testing to check how your tricuspid valve is functioning. People with conditions like lupus, Marfan syndrome, or rheumatoid arthritis also face higher risks and should discuss screening with their doctors.

Sometimes tricuspid valve disease is discovered unexpectedly during imaging tests performed for completely different reasons. This is actually quite common, especially with mild forms of the disease. If your doctor notices something unusual during a routine examination or imaging study, they may recommend additional diagnostic tests to better understand what's happening with your tricuspid valve.

Classic Diagnostic Methods

Diagnosing tricuspid valve disease begins with a thorough physical examination and conversation with your healthcare provider. During this initial assessment, your doctor will ask detailed questions about your symptoms, how long you've been experiencing them, and whether anything makes them better or worse. They'll also want to know about your medical history, including any previous heart problems, infections, surgeries, or medications you're currently taking.

During the physical exam, your doctor will perform several checks that can provide important clues about tricuspid valve function. One of the first things they'll do is listen to your heart using a stethoscope. When the tricuspid valve isn't working properly, it often produces a distinctive whooshing sound called a heart murmur. This sound occurs because blood is flowing in ways it shouldn't, either leaking backward through a valve that doesn't close properly or struggling to pass through a narrowed opening. The characteristics of this murmur, including when it occurs during your heartbeat and how loud it is, can help your doctor understand what type of valve problem you might have.

Your doctor will also carefully examine your neck veins. When the tricuspid valve leaks significantly, blood backs up into the right side of your heart and the veins that lead to it. This can cause the veins in your neck to become enlarged and visibly pulsate. By observing these veins, your healthcare provider can get a sense of how much pressure is building up in your heart's right chambers. They'll also check for swelling in your abdomen, legs, ankles, and feet, and feel your liver to see if it's enlarged or pulsating, which are signs that blood isn't flowing efficiently through the right side of your heart.

Echocardiogram: The Primary Diagnostic Tool

An echocardiogram is the most important and commonly used test for diagnosing tricuspid valve disease. This test uses ultrasound technology, which means it creates pictures of your heart using sound waves rather than radiation. It's painless and provides detailed, real-time images that show how your heart is beating, how blood is flowing through the chambers and valves, and whether the tricuspid valve is functioning properly.

There are two main types of echocardiograms. The standard version is called a transthoracic echocardiogram, or TTE. During this test, a technician places a small device called a transducer on your chest. The transducer sends sound waves through your chest wall to your heart and receives the echoes that bounce back. A computer then converts these echoes into moving images on a screen. The test is quick, usually taking about 30 to 60 minutes, and you can resume normal activities immediately afterward.

Sometimes, especially if the pictures from a standard echocardiogram aren't clear enough or if your doctor needs more detailed information about your tricuspid valve, they may recommend a transesophageal echocardiogram, or TEE. This test provides even clearer images because the ultrasound device is placed much closer to your heart. To perform a TEE, your doctor gently guides a thin, flexible tube with an ultrasound transducer on its tip down your esophagus (the tube that connects your mouth to your stomach). Because the esophagus sits directly behind the heart, this positioning allows for extremely detailed views of the heart structures, including the tricuspid valve. You'll be given medication to make you comfortable and numb your throat before the procedure.

The echocardiogram provides crucial information that helps doctors understand your condition. It can show whether the valve leaflets (the flaps that open and close) are moving properly, how much blood is leaking backward if regurgitation is present, whether the valve opening is narrowed, the size and function of your heart chambers, and the pressure in your lungs' blood vessels. All of this information helps determine how severe your tricuspid valve disease is and what treatment approach might be most appropriate.

Electrocardiogram (ECG or EKG)

An electrocardiogram, often abbreviated as ECG or EKG, is a simple, quick test that records the electrical activity of your heart. During this test, small adhesive patches called electrodes are placed on your chest, arms, and legs. These electrodes detect the tiny electrical signals that cause your heart to beat, and a machine records these signals as wavy lines on paper or a computer screen.

While an ECG doesn't directly show your tricuspid valve, it provides valuable information about how valve problems are affecting your heart. For example, if your right heart chambers are enlarged because of valve disease, this may show up as specific patterns in the electrical signals. The test can also detect irregular heart rhythms, which commonly occur alongside tricuspid valve disease, and show signs of strain on your heart muscle. The ECG takes only a few minutes and is completely painless.

Chest X-Ray

A chest X-ray uses a small amount of radiation to create pictures of the structures inside your chest, including your heart, lungs, and blood vessels. While it doesn't provide detailed information about valve function, it can reveal important clues about tricuspid valve disease. For instance, if your heart has become enlarged because the valve isn't working properly, this will be visible on the X-ray. The test can also show fluid buildup in your lungs or changes in the blood vessels leading to your lungs, which may occur with advanced valve disease.

Additional Imaging and Testing

Beyond these core tests, your doctor may recommend additional diagnostic procedures to get a complete picture of your heart health. Stress tests, for example, evaluate how your heart responds to physical exertion. These can be performed using either an ECG or echocardiogram while you exercise on a treadmill or stationary bike, or while medication increases your heart rate if you're unable to exercise. Stress testing helps doctors understand whether your symptoms are related to tricuspid valve disease and how much the condition limits your ability to be active.

Cardiac catheterization is an invasive procedure that may be recommended in certain situations, particularly if your doctor needs to measure pressures inside your heart chambers or evaluate your coronary arteries. During this test, a thin, flexible tube called a catheter is inserted into a blood vessel in your groin or arm and guided to your heart using X-ray imaging. While more complex than other tests, cardiac catheterization provides very precise measurements that can be crucial for treatment planning.

Advanced imaging techniques like cardiac CT scans or cardiac MRI may also be used in some cases. These tests create extremely detailed three-dimensional pictures of your heart and can help doctors see the structure of your tricuspid valve and heart chambers in great detail. They're particularly useful when planning surgical or catheter-based interventions.

Diagnostics for Clinical Trial Qualification

Clinical trials investigating new treatments for tricuspid valve disease use standardized diagnostic criteria to ensure that participants meet specific requirements. Understanding these criteria can help you know whether you might be eligible for research studies testing innovative therapies.

The primary diagnostic tool used in clinical trials for tricuspid valve disease is the echocardiogram. Trials typically require detailed echocardiographic assessment to confirm the presence and severity of tricuspid regurgitation or stenosis. Researchers use specific grading systems to classify the severity of valve leakage, ranging from trace or trivial (very minimal) through mild, moderate, and severe. For most clinical trials testing new treatments, participants must have at least moderate to severe tricuspid regurgitation documented by echocardiography.

In addition to confirming valve disease severity, trials often require measurements of how your heart chambers are functioning. This includes assessing the size and pumping function of your right ventricle (the lower right heart chamber), measuring the size of your right atrium (the upper right chamber), and evaluating the pressure in your pulmonary arteries. These measurements help researchers understand not just the valve problem itself, but also how it's affecting the rest of your cardiovascular system.

Clinical trials also typically require documentation of symptoms. Many studies ask participants to complete standardized questionnaires that assess how much their symptoms affect their daily life, their ability to perform physical activities, and their overall quality of life. These assessments help researchers understand whether new treatments are improving not just the valve function seen on tests, but also how patients actually feel and function in their everyday lives.

Blood tests may be required as part of trial screening to check your kidney and liver function, measure certain proteins that indicate heart strain, and ensure you don't have conditions that would make participation unsafe. Some trials also require a cardiac CT scan to provide detailed measurements of your heart anatomy, which helps determine whether you're a good candidate for specific catheter-based interventions being studied.

Eligibility for tricuspid valve clinical trials often depends on whether you're considered too high-risk for traditional open-heart surgery. This determination is typically made by a team of heart specialists reviewing your overall health status, age, other medical conditions, and previous surgeries. The goal of many current clinical trials is to offer treatment options to patients who previously had few alternatives because surgery was deemed too risky.

Prognosis and Survival Rate

Prognosis

The outlook for people with tricuspid valve disease depends significantly on the severity of the condition and how quickly treatment is provided. Mild tricuspid valve disease typically causes no symptoms and has little impact on daily life or overall health. People with mild cases can often live normally with regular monitoring by their healthcare provider.

However, moderate to severe tricuspid valve disease has a more serious impact on health and quality of life. When left untreated, severe tricuspid regurgitation can progressively enlarge and weaken the heart over time. This can lead to heart failure, where the heart struggles to pump enough blood to meet the body's needs. The condition can also cause irregular heart rhythms and increase the risk of other cardiovascular complications. The good news is that newer treatment options, including minimally invasive procedures, can greatly improve symptoms and quality of life for many patients who were previously considered too high-risk for traditional surgery.

Several factors influence the prognosis for people with tricuspid valve disease. These include the underlying cause of the valve problem, the presence of other heart conditions (particularly left-sided heart valve disease or heart failure), lung pressure levels, the function of the right ventricle, and whether treatment is pursued. People who undergo successful valve repair or replacement generally have better outcomes than those who receive only medical management for severe disease.

Survival Rate

The survival rates for tricuspid valve disease vary considerably based on severity and treatment. Studies have shown that people with severe tricuspid regurgitation and heart failure with reduced ejection fraction face particularly challenging outcomes, with a five-year survival rate of approximately 34% when the condition is not addressed.

Research on newer transcatheter treatments has shown promising results for improving survival and quality of life. In recent clinical trials, patients who underwent catheter-based tricuspid valve repair showed significant benefits. For example, at two years following treatment with transcatheter edge-to-edge repair, the risk of heart failure hospitalization was reduced by 28% compared to medical therapy alone.

It's important to understand that these statistics represent large groups of patients and may not reflect your individual situation. Many factors influence outcomes, including your age, overall health, other medical conditions, the specific type of tricuspid valve disease you have, and how early the condition is diagnosed and treated. Your healthcare team can provide more personalized information about your prognosis based on your specific circumstances.

Did you know?

  1. The tricuspid valve was once called the "forgotten valve" because it received far less medical attention than other heart valves, but recent technological advances have dramatically changed how doctors diagnose and treat problems with this important structure.[11]
  2. Women are more than four times more likely to develop tricuspid valve regurgitation than men, making it essential for women to be particularly aware of symptoms and screening recommendations.[10]
  3. Trace tricuspid regurgitation (a very small amount of backward blood flow) is actually common and completely harmless in healthy people, appearing on echocardiograms in many individuals who have no symptoms or problems.[16]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Tricuspid valve disease

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Pohjois-Savon hyvinvointialue
See all 1 trials →filters applied: condition = Tricuspid valve disease

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).